Kitov Pharmaceuticals is a leading brand that is dedicated to providing innovative and effective therapies for cancer patients. Their mission is to overcome tumor immune evasion and drug resistance, ultimately improving treatment outcomes for those battling cancer. With a strong focus on harnessing the power of the tumor microenvironment (TME), Kitov Pharmaceuticals develops first-in-class therapies that deliver lasting results.

Located at their corporate headquarters in Science Park, Rehovot Israel, Kitov Pharmaceuticals is at the forefront of cutting-edge research and development. Their pipeline offers a comprehensive range of therapies, including CM24, NT219, and IM1240, which have shown tremendous promise in overcoming the challenges of drug resistance. Driven by a team of experienced professionals, including their executive team, board of directors, and scientific advisory board, Kitov Pharmaceuticals is committed to making a difference in the lives of cancer patients.

Stay informed about their latest developments through their website and social media platforms, and join them in their mission to revolutionize cancer treatment